Safety and Effectiveness of Novantrone Therapy Followed by Copaxone
- Study Title
- A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis.
- Teva Identifier
- NC-100
- ClinicalTrials.gov Identifier
- NCT00203073
- Study Status
- Completed
- Trial Condition(s)
- Relapsing Remitting Multiple Sclerosis
- Interventions
- Drug: glatiramer acetate 20 mg | Drug: glatiramer acetate 20 mg, with mitoxantrone
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult
- Age Range
- 18 Years to 55 Years
- Trial Duration
- 06/01/2003 - 04/01/2005
- Phase
- Phase 2
